| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/18/2004 | US6737241 Methods for screening for transdominant intracellular effector peptides and RNA molecules |
| 05/18/2004 | US6737234 Generating a mutant adenovirus characterized by a receptor binding affinity which is significantly weakened for card1 (catalyzed reporter deposition) relative to wild-type adenovirus |
| 05/13/2004 | WO2003068163A3 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 05/13/2004 | US20040092730 Hepatitis C virus non-structural NS3/4A fusion gene |
| 05/13/2004 | US20040092008 Recombinant AAV vectors for gene therapy of hemophilia A |
| 05/13/2004 | US20040091996 Genetically engineered virus which propagates specifically in tumor cells and codes angiogensis inhibitors; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091995 Replication defective poxvirus coding granulocyte-monocyte-colony stimulating factor (GM-CSF) for treatment and prevention of neutropenia and tumor disorders; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/13/2004 | US20040091878 Zinc finger domain recognition code and uses thereof |
| 05/13/2004 | US20040091853 Features a chimeric protein containing beta-lactamase and Vpr/Vpx region; for lentivirus/human immunodeficiency virus (HIV) |
| 05/13/2004 | US20040091457 Compositions and methods for inhibiting viral replication |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1417323A2 Humanised baculovirus |
| 05/12/2004 | EP1147181B1 Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer |
| 05/12/2004 | CN1496268A Vesicular stromatitis virus (VSV) |
| 05/12/2004 | CN1495255A Method for obtaining non-occluded baculovirus |
| 05/12/2004 | CN1495190A Polynuleotide fragment of white-spot disease baculovirus and method for detecting virus by using it |
| 05/11/2004 | US6734008 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/11/2004 | US6733993 Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications |
| 05/11/2004 | US6733757 Adeno-associated virus capsid polypeptide for use as gene transfer tool in cell tranduction |
| 05/11/2004 | US6732573 Single riser/single capillary blood viscometer using mass detection or column height detection |
| 05/11/2004 | CA2218358C Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same |
| 05/06/2004 | WO2004038029A1 Method of transferring gene into t cells |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037202A2 Gb virus c and methods of treating viral infections |
| 05/06/2004 | WO2003062407A8 INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF |
| 05/06/2004 | WO2003031567A9 Precursor conversion screening methods |
| 05/06/2004 | WO2002062827A3 Improved protein disaggregation and refolding using high pressure |
| 05/06/2004 | US20040087002 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 05/06/2004 | US20040087001 Transgenic viral particles to enhance cell fusion and transfer genetic material into polymorphonuclear leukocytes (PMNL); gene therapy |
| 05/06/2004 | US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines |
| 05/06/2004 | US20040086529 Vaccines containing ribavirin and methods of use thereof |
| 05/06/2004 | US20040086527 Vaccine for conferring protection against human papillomavirus (HPV) infection in a human |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086490 Nucleic acid vector comprising a pair of adeno-associated virus 4 (AAV4) inverted terminal repeats and a promoter between the inverted terminal repeats |
| 05/06/2004 | US20040086489 Recombinant cytomegalovirus comprising a cytomegalovirus genome that comprises a heterologous nucleotide sequence encoding a heterologous chemokine receptor or ligand |
| 05/06/2004 | EP1415669A1 Process for sterilization of protein containing biological compositions |
| 05/06/2004 | EP1415005A2 Endogenous retroviruses up-regulated in prostate cancer |
| 05/06/2004 | EP1414984A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0729509B1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/06/2004 | CA2503317A1 Method of transferring gene into t cells |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/04/2004 | US6730512 Combination immunogene therapy |
| 05/04/2004 | US6730511 Vectors that repress heterologous promoter activity |
| 05/04/2004 | US6730507 Helper virus based on the ad2 and ad5 (adenovirus) serotype to produce genetically identical hdad (helper-dependent adenovirus) that differ only in the virion protein components ; for gene therapy, genetic vaccines |
| 05/04/2004 | US6730306 Plant antigens |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | CA2120137C Feline leukemia virus vaccines |
| 04/29/2004 | WO2004035779A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/29/2004 | WO2004035616A2 Adenovirus expressing genes in reverse order and use thereof |
| 04/29/2004 | WO2004034956A2 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 04/29/2004 | WO2004016151A3 Pthrp-derived modulators of smooth muscle proliferation |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081636 Genetic engineering; polynucleotides |
| 04/29/2004 | DE10248301A1 Herstellung eines Lebend-Impfstoffes gegen Influenza-Viren Preparation of a live vaccine against influenza viruses |
| 04/29/2004 | CA2515650A1 New adenoviruses, nucleic acids coding therefor and their use |
| 04/29/2004 | CA2497313A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/28/2004 | EP1412510A2 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection |
| 04/28/2004 | EP1412493A2 Methods and compositions relating to improved lentiviral vector production systems |
| 04/28/2004 | EP1412486A2 Method for virus propagation |
| 04/28/2004 | EP1411880A2 Recombinant vsv for the treatment of tumor cells |
| 04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 04/28/2004 | CN1492923A 减毒的活疫苗 Attenuated live vaccine |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147316C Process for preparing influenza virus vaccine by static hydraulic inactivation |
| 04/27/2004 | US6727058 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 04/27/2004 | US6726907 Purified adenoviral compositions |
| 04/27/2004 | CA2096888C Process for the inactivation of viruses in preparations of proteins |
| 04/22/2004 | WO2004033696A2 Recombinant adenoviral vectors and applications thereof |
| 04/22/2004 | WO2004033690A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | WO2004032959A2 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 04/22/2004 | WO2004032622A2 Production of peptides in plants as viral coat protein fusions |
| 04/22/2004 | WO2003103571A3 Flavivirus vaccines |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003046506A3 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies |
| 04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 04/22/2004 | WO2003022202A9 Compositions and methods for treatment of cancer |
| 04/22/2004 | WO2003020893A3 New adenovirus type 7 vectors |
| 04/22/2004 | US20040077577 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |
| 04/22/2004 | US20040077086 Animal protein free media for cultivation of cells |
| 04/22/2004 | US20040077066 Purified active HCV NS2/3 protease |
| 04/22/2004 | US20040076644 Immunogenic preparation that is recognized as a specific monoclonal antibody and a veterinarily acceptable vehicle or excipient |
| 04/22/2004 | US20040076642 Equine abortion virus |
| 04/22/2004 | US20040076632 DNA vaccine against feline immunodeficiency virus |
| 04/22/2004 | US20040076612 For drug screening hepatitis C virus drugs |
| 04/22/2004 | US20040076611 Molecular antigen arrays |
| 04/22/2004 | CA2501633A1 Recombinant adenoviral vectors and applications thereof |
| 04/22/2004 | CA2501289A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | CA2498768A1 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics |
| 04/22/2004 | CA2497798A1 Production of peptides in plants as viral coat protein fusions |
| 04/21/2004 | EP1411128A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 04/21/2004 | EP1409700A2 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same |
| 04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |